Cassava Sciences Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Direxion Daily Semiconductor Bull 3X Shares trades at $141.36. The key difference: Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SOXL | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.64 | $300.77 |
52-Week Low | $1.09 | $23.99 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
SOXL, the Direxion Daily Semiconductor Bull 3X Shares ETF, is trading at $145.35, down 17.72% in the past 24 hours amid a broader semiconductor selloff. Technical indicators show a bearish trend with support at $125 and resistance at $178, while RSI levels near 35 suggest potential oversold conditions. Recent news highlights volatility driven by SK Hynix's U.S. listing and increased competition in memory chips, impacting leveraged ETF performance.
The outlook for SOXL remains highly volatile due to its 3x leverage on semiconductor stocks, amplifying both gains and losses. Investment opportunity exists if semiconductor sentiment rebounds, but risks include decay from choppy markets and sector-specific pressures. Caution is warranted given the bearish technical signals and recent institutional selling.
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →